Capitalizing hope: the commercial development of umbilical cord blood stem cell banking

Paul A Martin, Nik Brown, Andrew Turner

Research output: Contribution to journalArticle (Academic Journal)

69 Citations (Scopus)

Abstract

The creation of commercial cord blood banks rests on the promise of stem cell based regenerative medicine and marks the capitalization of human tissues within a future-oriented ?regime of hope?. This paper will present data from a survey of the international cord blood banking industry and will explore: (a) the way firms seek to commercialize cord blood as a new set of commodities; (b) the expectations and moral economy that are being constructed around this technology; and (c) how firms are acting as mediators of hope in what might be called a ?promissory bioeconomy?.
Original languageEnglish
Pages (from-to)127-143
Number of pages17
JournalNew Genetics and Society
Volume27
Issue number2
DOIs
Publication statusPublished - 2008

Fingerprint Dive into the research topics of 'Capitalizing hope: the commercial development of umbilical cord blood stem cell banking'. Together they form a unique fingerprint.

  • Cite this